Skip to content

Real-world registry study of early standardized diagnosis, treatment and prognosis of acute ischemic stroke: a prospective and observational study

Real-world registry study of early standardized diagnosis, treatment and prognosis of acute ischemic stroke: a prospective and observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044101
Enrollment
Unknown
Registered
2021-03-11
Start date
2021-03-12
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

case series:Nil

Sponsors

Mianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The admission was diagnosed as acute ischemic stroke, which meets the diagnostic criteria of ischemic stroke in the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2014"; 2. Family members or patients agree and sign an informed consent form for follow-up registration; 3. Age over 18 years old; 4. Onset within 72 hours; 5. For patients with intravenous thrombolysis, receive intravenous thrombolysis within 4.5 hours of the confirmed onset time; 6. For patients with arterial thrombus removal, the onset time is 6 hours of large vessel occlusion, or the onset time is longer but has an ischemic penumbra through multimodal impact assessment and meets the guidelines recommended standards; 7. The patient and the client are willing to sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Intracranial hemorrhagic diseases: cerebral hemorrhage, subarachnoid hemorrhage, etc.; 2. Patients suffering from claustrophobia, pacemaker implantation, DBS implantation, etc. who cannot complete head MRI; 3. Patients who have undergone surgery with metal implantation and cannot complete cranial MRI; 4. Those who cannot complete the research due to mental illness, cognitive or emotional disorders; 5. Poor compliance or inability to complete or refuse to complete the follow-up study; 6. The mRS score is > 2 points before onset.

Design outcomes

Primary

MeasureTime frame
The proportion of mRS less than or equal to 2 points;

Countries

China

Contacts

Public ContactZhonglun Chen

Mianyang Central Hospital

mchczl@163.com+86 13990169235

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026